ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks. MASON, Ohio, October 15, 2024--AtriCure ...
JPMorgan analyst Lilia-Celine Lozada assumed coverage of AtriCure (ATRC) with an Overweight rating and $40 price target With numbers reset and competitive headwinds not materializing as feared ...
Canaccord analyst William Plovanic raised the firm’s price target on AtriCure (ATRC) to $61 from $53 and keeps a Buy rating on the shares. Canaccord said they are bullish on the Med-Tech sector ...
Abstract: We introduce ICE-TIDE, a method for cryogenic electron tomography (cryo-ET) that simultaneously aligns observations and reconstructs a high-resolution volume. The alignment of tilt series in ...
In the latest quarter, 6 analysts provided ratings for AtriCure (NASDAQ ... Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...